Patents Assigned to O-RAY PHARMA, INC.
  • Patent number: 11291671
    Abstract: The present invention provides for pharmaceutical preparations, devices, systems and methods for the treatment of otic diseases and conditions. In various embodiments, the preparations, devices, systems and methods enable sustained drug release for the treatment or prevention of hearing loss, infections, and other pathological conditions of cochlea and inner ear.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: April 5, 2022
    Assignee: O-Ray Pharma, Inc.
    Inventors: William H. Slattery, Thomas Smith, Erik Pierstorff, Marc M. Baum
  • Publication number: 20160250231
    Abstract: The present invention provides for pharmaceutical preparations, devices, systems and methods for the treatment of otic diseases and conditions. In various embodiments, the preparations, devices, systems and methods enable sustained drug release for the treatment or prevention of hearing loss, infections, and other pathological conditions of cochlea and inner ear.
    Type: Application
    Filed: May 13, 2016
    Publication date: September 1, 2016
    Applicant: O-Ray Pharma, Inc.
    Inventors: William H. Slattery, Thomas Smith, Erik Pierstorff, Marc M. Baum
  • Publication number: 20150202161
    Abstract: The present invention provides for methods of producing a drug product that is capable of providing controlled and sustained release of a drug. Particularly, the release of the drug will be to a specific tissue area in the body. The methods include, but are not limited to, providing an impermeable casing with an open end, placing a compressed drug pellet into the impermeable casing, coating the open end of the impermeable casing with a permeable layer to create a release window for the drug product to provide controlled and/or sustained release of the drug.
    Type: Application
    Filed: August 20, 2013
    Publication date: July 23, 2015
    Applicant: O-RAY PHARMA, INC.
    Inventors: Erik Pierstorff, William H. Slattery
  • Publication number: 20150044271
    Abstract: The present invention provides for pharmaceutical preparations, devices, systems and methods for the treatment of otic diseases and conditions. In various embodiments, the preparations, devices, systems and methods enable sustained drug release for the treatment or prevention of hearing loss, infections, and other pathological conditions of cochlea and inner ear.
    Type: Application
    Filed: February 27, 2013
    Publication date: February 12, 2015
    Applicant: O-RAY PHARMA, INC.
    Inventors: William H. Slattery, Thomas Smith, Erik Pierstorff, Marc M. Baum